NRC Health (NASDAQ: NRC) Stock Competitors & Peer Comparison
See NRC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NRC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NRC | $21.78 | -0.73% | 490.8M | 26.56 | $0.82 | +2.76% |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
NRC vs VEEV Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas VEEV's P/E ratio is 23.46. In terms of profitability, NRC's ROE is +0.57%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, NRC is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for NRC.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NRC vs GEHC Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas GEHC's P/E ratio is 13.83. In terms of profitability, NRC's ROE is +0.57%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, NRC is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NRC vs GEHCV Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, NRC is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NRC vs BTSG Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas BTSG's P/E ratio is 57.01. In terms of profitability, NRC's ROE is +0.57%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, NRC is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
NRC vs BTSGU Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, NRC's ROE is +0.57%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, NRC is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NRC vs TEM Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas TEM's P/E ratio is -104.94. In terms of profitability, NRC's ROE is +0.57%, compared to TEM's ROE of -0.70%. Regarding short-term risk, NRC is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for NRC.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
NRC vs SGFY Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NRC's ROE is +0.57%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NRC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NRC vs HQY Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HQY's P/E ratio is 23.06. In terms of profitability, NRC's ROE is +0.57%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NRC is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
NRC vs HNGE Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HNGE's P/E ratio is 44.66. In terms of profitability, NRC's ROE is +0.57%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, NRC is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
NRC vs RCM Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas RCM's P/E ratio is -102.21. In terms of profitability, NRC's ROE is +0.57%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NRC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
NRC vs TXG Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas TXG's P/E ratio is -257.29. In terms of profitability, NRC's ROE is +0.57%, compared to TXG's ROE of -0.03%. Regarding short-term risk, NRC is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
NRC vs DOCS Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas DOCS's P/E ratio is 14.07. In terms of profitability, NRC's ROE is +0.57%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, NRC is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NRC vs ONEM Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NRC's ROE is +0.57%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NRC is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NRC vs PRVA Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas PRVA's P/E ratio is 168.13. In terms of profitability, NRC's ROE is +0.57%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
NRC vs PGNY Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas PGNY's P/E ratio is 23.31. In terms of profitability, NRC's ROE is +0.57%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, NRC is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NRC vs HTFL Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HTFL's P/E ratio is -12.92. In terms of profitability, NRC's ROE is +0.57%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, NRC is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
NRC vs WGS Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas WGS's P/E ratio is 74.68. In terms of profitability, NRC's ROE is +0.57%, compared to WGS's ROE of -0.28%. Regarding short-term risk, NRC is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for NRC.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NRC vs TDOC Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas TDOC's P/E ratio is -10.47. In terms of profitability, NRC's ROE is +0.57%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, NRC is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
NRC vs NXGN Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas NXGN's P/E ratio is -266.00. In terms of profitability, NRC's ROE is +0.57%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, NRC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
NRC vs OMDA Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas OMDA's P/E ratio is 338.57. In terms of profitability, NRC's ROE is +0.57%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, NRC is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
NRC vs AGTI Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NRC's ROE is +0.57%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NRC vs GDRX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas GDRX's P/E ratio is 9.52. In terms of profitability, NRC's ROE is +0.57%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NRC is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
NRC vs CERT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CERT's P/E ratio is 17.77. In terms of profitability, NRC's ROE is +0.57%, compared to CERT's ROE of -0.01%. Regarding short-term risk, NRC is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NRC vs CCLDO Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NRC vs HSTM Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HSTM's P/E ratio is 38.08. In terms of profitability, NRC's ROE is +0.57%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NRC is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
NRC vs WGSWW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.57%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, NRC is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
NRC vs PHR Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, PHR has a market cap of 662M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas PHR's P/E ratio is 38.25. In terms of profitability, NRC's ROE is +0.57%, compared to PHR's ROE of +0.03%. Regarding short-term risk, NRC is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
NRC vs EVH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas EVH's P/E ratio is 580.00. In terms of profitability, NRC's ROE is +0.57%, compared to EVH's ROE of -0.78%. Regarding short-term risk, NRC is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NRC vs MPLN-WT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, NRC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
NRC vs ACCD Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NRC's ROE is +0.57%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NRC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NRC vs SHCR Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NRC's ROE is +0.57%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NRC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
NRC vs CTEV Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CTEV's P/E ratio is -2.33. In terms of profitability, NRC's ROE is +0.57%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, NRC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NRC vs SOPH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SOPH's P/E ratio is -11.29. In terms of profitability, NRC's ROE is +0.57%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, NRC is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NRC vs SLGC Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NRC's ROE is +0.57%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NRC vs SLGCW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NRC's ROE is +0.57%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NRC vs TBRG Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NRC's ROE is +0.57%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NRC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
NRC vs MPLN Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NRC's ROE is +0.57%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, NRC is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
NRC vs SLP Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SLP's P/E ratio is 20.72. In terms of profitability, NRC's ROE is +0.57%, compared to SLP's ROE of +0.06%. Regarding short-term risk, NRC is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NRC vs TRHC Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NRC's ROE is +0.57%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NRC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NRC vs SMFR Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SMFR's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, NRC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NRC vs SPOK Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SPOK's P/E ratio is 17.73. In terms of profitability, NRC's ROE is +0.57%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, NRC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
NRC vs SY Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SY's P/E ratio is -5.09. In terms of profitability, NRC's ROE is +0.57%, compared to SY's ROE of -0.16%. Regarding short-term risk, NRC is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SY's competition here
American Well Corporation (NYSE: AMWL)
NRC vs AMWL Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas AMWL's P/E ratio is -2.54. In terms of profitability, NRC's ROE is +0.57%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, NRC is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NRC vs HCAT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HCAT's P/E ratio is 11.25. In terms of profitability, NRC's ROE is +0.57%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, NRC is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NRC vs CPSI Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NRC's ROE is +0.57%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NRC is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NRC vs OPRX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas OPRX's P/E ratio is 6.14. In terms of profitability, NRC's ROE is +0.57%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, NRC is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NRC vs AUGX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NRC's ROE is +0.57%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NRC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NRC vs CCLD Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CCLD's P/E ratio is 8.59. In terms of profitability, NRC's ROE is +0.57%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NRC vs DH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas DH's P/E ratio is 2.92. In terms of profitability, NRC's ROE is +0.57%, compared to DH's ROE of -0.67%. Regarding short-term risk, NRC is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
NRC vs FORA Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas FORA's P/E ratio is -24.11. In terms of profitability, NRC's ROE is +0.57%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NRC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NRC vs CCLDP Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NRC vs ONMD Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ONMD's P/E ratio is -4.53. In terms of profitability, NRC's ROE is +0.57%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, NRC is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NRC vs SNCE Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NRC's ROE is +0.57%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NRC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NRC vs AKLI Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NRC's ROE is +0.57%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NRC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NRC vs SHLT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NRC's ROE is +0.57%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NRC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NRC vs SHCRW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.57%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NRC is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NRC vs ONMDW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ONMDW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, NRC is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NRC vs STRM Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas STRM's P/E ratio is -2.40. In terms of profitability, NRC's ROE is +0.57%, compared to STRM's ROE of -0.32%. Regarding short-term risk, NRC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NRC vs RNLX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NRC's ROE is +0.57%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NRC is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NRC vs LIFW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.57%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
NRC vs EUDA Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas EUDA's P/E ratio is -21.32. In terms of profitability, NRC's ROE is +0.57%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, NRC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
NRC vs BBLN Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +0.57%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NRC is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
NRC vs BEATW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas BEATW's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +0.57%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, NRC is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NRC vs ETAO Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +0.57%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NRC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NRC vs BFRG Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas BFRG's P/E ratio is -1.20. In terms of profitability, NRC's ROE is +0.57%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, NRC is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
NRC vs HLTH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HLTH's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.57%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, NRC is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
NRC vs SCNX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas SCNX's P/E ratio is -0.16. In terms of profitability, NRC's ROE is +0.57%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, NRC is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
NRC vs UPH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas UPH's P/E ratio is -0.07. In terms of profitability, NRC's ROE is +0.57%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NRC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NRC vs UPH-WT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, NRC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NRC vs MGRX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MGRX's P/E ratio is -0.31. In terms of profitability, NRC's ROE is +0.57%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, NRC is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NRC vs PEAR Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NRC's ROE is +0.57%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NRC vs PEARW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.57%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NRC vs OTRK Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.57%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NRC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NRC vs VSEEW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, NRC's ROE is +0.57%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, NRC is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NRC vs HCTI Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas HCTI's P/E ratio is -0.23. In terms of profitability, NRC's ROE is +0.57%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, NRC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
NRC vs CMAX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.57%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NRC vs VSEE Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas VSEE's P/E ratio is -0.19. In terms of profitability, NRC's ROE is +0.57%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, NRC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for NRC.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
NRC vs ACON Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ACON's P/E ratio is -0.24. In terms of profitability, NRC's ROE is +0.57%, compared to ACON's ROE of -0.54%. Regarding short-term risk, NRC is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NRC vs LIFWZ Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
NRC vs EUDAW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, NRC's ROE is +0.57%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, NRC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
NRC vs WORX Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas WORX's P/E ratio is -0.76. In terms of profitability, NRC's ROE is +0.57%, compared to WORX's ROE of -0.65%. Regarding short-term risk, NRC is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NRC vs MSPRZ Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, NRC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
NRC vs KERN Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas KERN's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +0.57%, compared to KERN's ROE of -0.17%. Regarding short-term risk, NRC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
NRC vs KERNW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.57%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, NRC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NRC vs LIFWW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NRC vs ZCMD Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, NRC's ROE is +0.57%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, NRC is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NRC vs CMAXW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NRC vs ACONW Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas ACONW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, NRC is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NRC vs MTBCO Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NRC vs MSPRV Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NRC is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NRC vs MTBCP Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NRC vs MTBC Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas MTBC's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, NRC is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
NRC vs CHNG Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CHNG's P/E ratio is -152.72. In terms of profitability, NRC's ROE is +0.57%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NRC vs CHNGU Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
NRC vs CNVY Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CNVY's P/E ratio is -71.50. In terms of profitability, NRC's ROE is +0.57%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
NRC vs NAVA Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas NAVA's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.57%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, NRC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for NRC.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
NRC vs CERN Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CERN has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CERN's P/E ratio is 55.84. In terms of profitability, NRC's ROE is +0.57%, compared to CERN's ROE of +0.14%. Regarding short-term risk, NRC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
NRC vs CSLT Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas CSLT's P/E ratio is -37.27. In terms of profitability, NRC's ROE is +0.57%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, NRC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
NRC vs NH Comparison July 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 490.8M. In comparison, NH has a market cap of 0. Regarding current trading prices, NRC is priced at $21.78 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 26.56, whereas NH's P/E ratio is -0.12. In terms of profitability, NRC's ROE is +0.57%, compared to NH's ROE of +0.35%. Regarding short-term risk, NRC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check NH's competition here